Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte vs Geloplasma in CPB Priming
NCT02034682Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hetastarch in coronary artery disease (CAD) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: StO2 recovery slope. Started Jan 2014; status: completed.
02
Drugs
hetastarch
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02034682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034682.